Bank of America Spends Over $250 Million Annually on Employee Weight Loss Drugs

Bank of America (BoA) is spending over $250 million annually to provide GLP-1 weight loss drugs to its employees.The company's CEO Brian Moynihan revealed the information in an interview with CNBC .He said the cost has increased from nothing about five years ago, but he believes it's a "good investment" considering the potential health benefits for employees in the near and long term.